print email comment close Postmarket Drug Safety Information for Patients and Providers URL: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/default.htm Description: In 2005 the FDA proposed creating the Drug Watch Web Page, a new program that would communicate "the most up-to-date information possible on emerging [drug] safety issues to the public, even before FDA ... decides whether a regulatory action is appropriate." Includes guidance from the FDA, drug specific information for health professionals and consumers, and related information. From the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER). Publisher: U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) Extra Keywords Emerging Drug Safety Library of Congress Subject Headings: Drugs -- Safety measures United States. Food and Drug Administration LII Database Information: Record 12711 created by Maria Brandt on 06/10/2005 Last modification on 09/09/2009 Published: 06/10/2005   Funding agency: California State Library LII Item ID: http://lii.org/cs/lii/view/item/12711